John Hohneker

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Cambridge, MA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Diantha Duvall, Attorney-in-fact
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for John Hohneker

Form 4 holding Director

HUMANIGEN, INC

Security class
Stock Option (Right to Buy)
Shares / value
63,195
Estimated value
$286,273
Report date
27 Jul 2022
Price
$4.53
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

CURIS INC

Security class
Non Qualified Stock Option
Shares / value
6,800
Estimated value
$45,072
Report date
07 Jul 2026
Price
$3.13
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Aravive, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
97,063
Estimated value
Report date
23 Sep 2022
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Evelo Biosciences, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
20,000
Estimated value
Report date
08 Jun 2023
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Carisma Therapeutics Inc.

Security class
Stock Option (Right to Buy)
Shares / value
19,350
Estimated value
Report date
26 Jun 2024
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

ArriVent BioPharma, Inc.

Security class
Non-Qualified Stock Option (right to buy)
Shares / value
13,562
Estimated value
Report date
18 Jun 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by John Hohneker

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .